---
title: "Heliogen | 10-Q: FY2025 Q1 EPS: USD -1.03"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239192088.md"
datetime: "2025-05-07T20:06:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239192088.md)
  - [en](https://longbridge.com/en/news/239192088.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239192088.md)
generator: "portal-rs"
---

# Heliogen | 10-Q: FY2025 Q1 EPS: USD -1.03

EPS: As of FY2025 Q1, the actual value is USD -1.03.

### Segment Revenue

-   **Total Revenue**: The company did not recognize any revenue during the three months ended March 31, 2025, as there were no active revenue-generating projects at the time.

### Operational Metrics

-   **Net Loss**: The net loss for the three months ended March 31, 2025, was $6.4 million, compared to a net loss of $15.2 million for the same period in 2024.
-   **Operating Loss**: The operating loss for the three months ended March 31, 2025, was $6.9 million, compared to $16.1 million for the same period in 2024.
-   **Selling, General and Administrative Expenses**: SG&A expenses decreased to $4.6 million for the three months ended March 31, 2025, from $12.4 million for the same period in 2024.
-   **Research and Development Expenses**: R&D expenses decreased to $1.1 million for the three months ended March 31, 2025, from $3.8 million for the same period in 2024.

### Cash Flow

-   **Net Cash Used in Operating Activities**: Net cash used in operating activities was $8.4 million for the three months ended March 31, 2025, compared to $14.3 million for the same period in 2024.
-   **Net Cash Provided by Investing Activities**: Net cash provided by investing activities was $54 thousand for the three months ended March 31, 2025, compared to $9.9 million for the same period in 2024.

### Unique Metrics

-   **Impairment and Other Charges**: Impairment and other charges for the three months ended March 31, 2025, were $1.2 million, primarily due to a right-of-use asset impairment and costs associated with closing the Manufacturing Facility.

### Future Outlook and Strategy

-   **Core Business Focus**: The company is undergoing a significant transition to align its operating structure with a technology-centric business model, prioritizing the commercial deployment of its energy solutions.
-   **Non-Core Business**: The company has closed its Manufacturing Facility and R&D facility, halted construction of the Texas Steam Plant, and is exploring strategic transactions, including acquisitions, divestitures, mergers, or partnerships.
-   **Priority**: The company plans to continue exploring cost-saving opportunities and strategic transactions to alleviate liquidity concerns and align its operations with its technology-centric business model.

### Related Stocks

- [HLGN.US](https://longbridge.com/en/quote/HLGN.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**